Skip to main content
Premium Trial:

Request an Annual Quote

QTL Biosystems Lightspeed and EMD Biosciences Signal Transduction Interactive Pathways

Premium

QTL Biosystems has announced four new additions to its Lightspeed fluorescence-based kinase and protease assays: PKC-alpha (diabetes and leukemia screening), Akt-1 (cancer), Src (cancer), and p38-alpha (leukemia and lymphoma). QTL said the homogenous assays, which can be read with most commercially available fluorescence spectrometers and multiwell plate readers, are scalable from 96- to 3,456-well formats, and feature limits of detection in the picomolar range.


EMD Biosciences, a part of Merck KgaA’s Life Science and Analytics division, has released several new Signal Transduction Interactive Pathways on its website. The Interactive Pathways provide researchers with graphical tools that depict known interactions that occur in cell signaling and can affect disease development, EMD said. Clicking on a component of a pathway displays information about related EMD products, including antibodies, inhibitors, enzymes, proteins, enzyme substrates, and kits, the company said.

 

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.